Clinical Trial

Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-05.
Trial Details
NCT Number NCT07269392
Lead Sponsor National Taiwan University Hospital
Conditions In Vitro Fertilization (IVF), Embryo Transfer
Enrollment 170 participants
Start Date 2026-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16